{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:15:21Z","timestamp":1789064121902,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100016305","name":"The First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s11010-017-2944-x","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T10:08:02Z","timestamp":1486462082000},"page":"167-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Isorhamnetin protects against cardiac hypertrophy through blocking PI3K\u2013AKT pathway"],"prefix":"10.1007","volume":"429","author":[{"given":"Lu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"2944_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00395-013-0338-0","volume":"108","author":"K Chen","year":"2013","unstructured":"Chen K, Gao L, Liu Y, Zhang Y, Jiang DS, Wei X et al (2013) Vinexin-\u03b2 protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway. Basic Res Cardiol 108:338","journal-title":"Basic Res Cardiol"},{"key":"2944_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrd3431","volume":"10","author":"J Tamargo","year":"2011","unstructured":"Tamargo J, Lopez-Sendon J (2011) Novel therapeutic targets for the treatment of heart failure. Nat Rev Drug Discov 10:536\u2013555","journal-title":"Nat Rev Drug Discov"},{"key":"2944_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","volume":"9","author":"N Koitabashi","year":"2012","unstructured":"Koitabashi N, Kass DA (2012) Reverse remodeling in heart failure\u2013mechanisms and therapeutic opportunities. Nat Rev Cardiol 9:147\u2013157","journal-title":"Nat Rev Cardiol"},{"key":"2944_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2944_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470\u2013479","journal-title":"Circulation"},{"key":"2944_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1172\/JCI24178","volume":"115","author":"GW Dorn 2nd","year":"2005","unstructured":"Dorn GW 2nd, Force T (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115:527\u2013537","journal-title":"J Clin Invest"},{"key":"2944_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/HYPERTENSIONAHA.114.04806","volume":"65","author":"L Gao","year":"2015","unstructured":"Gao L, Huang K, Jiang DS, Liu X, Huang D, Li H et al (2015) Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy. Hypertension 65:871\u2013881","journal-title":"Hypertension"},{"key":"2944_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00109-008-0423-2","volume":"87","author":"Q Tang","year":"2009","unstructured":"Tang Q, Cai J, Shen D, Bian Z, Yan L, Wang YX et al (2009) Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT\/GSK3beta signaling. J Mol Med 87:249\u2013260","journal-title":"J Mol Med"},{"key":"2944_CR9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/jcb.22495","volume":"109","author":"L Yan","year":"2010","unstructured":"Yan L, Huang H, Tang QZ, Zhu LH, Wang L, Liu C et al (2010) Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling. J Cell Biochem 109:1158\u20131171","journal-title":"J Cell Biochem"},{"key":"2944_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jcb.22623","volume":"110","author":"W Ai","year":"2010","unstructured":"Ai W, Zhang Y, Tang QZ, Yan L, Bian ZY, Liu C et al (2010) Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. J Cell Biochem 110:1111\u20131122","journal-title":"J Cell Biochem"},{"key":"2944_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-2006-958110","volume":"61","author":"JC Park","year":"1995","unstructured":"Park JC, Young HS, Yu YB, Lee JH (1995) Isorhamnetin sulphate from the leaves and stems of Oenanthe javanica in Korea. Planta Med 61:377\u2013378","journal-title":"Planta Med"},{"key":"2944_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.fct.2013.05.049","volume":"59","author":"JH Yang","year":"2013","unstructured":"Yang JH, Kim SC, Shin BY, Jin SH, Jo MJ, Jegal KH et al (2013) O-Methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-kappaB activation. Food Chem Toxicol 59:362\u2013372","journal-title":"Food Chem Toxicol"},{"key":"2944_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.phrs.2006.04.007","volume":"54","author":"BS Teng","year":"2006","unstructured":"Teng BS, Lu YH, Wang ZT, Tao XY, Wei DZ (2006) In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells. Pharmacol Res 54:186\u2013194","journal-title":"Pharmacol Res"},{"key":"2944_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.taap.2013.10.026","volume":"274","author":"JH Yang","year":"2014","unstructured":"Yang JH, Shin BY, Han JY, Kim MG, Wi JE, Kim YW et al (2014) Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes. Toxicol Appl Pharmacol 274:293\u2013301","journal-title":"Toxicol Appl Pharmacol"},{"key":"2944_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.etp.2009.09.005","volume":"63","author":"N Zhang","year":"2011","unstructured":"Zhang N, Pei F, Wei H, Zhang T, Yang C, Ma G et al (2011) Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury. Exp Toxicol Pathol 63:33\u201338","journal-title":"Exp Toxicol Pathol"},{"key":"2944_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jcb.23371","volume":"113","author":"B Sun","year":"2012","unstructured":"Sun B, Sun GB, Xiao J, Chen RC, Wang X, Wu Y et al (2012) Isorhamnetin inhibits H(2)O(2)-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation. J Cell Biochem 113:473\u2013485","journal-title":"J Cell Biochem"},{"key":"2944_CR17","doi-asserted-by":"publisher","first-page":"e64526","DOI":"10.1371\/journal.pone.0064526","volume":"8","author":"J Sun","year":"2013","unstructured":"Sun J, Sun G, Meng X, Wang H, Luo Y, Qin M et al (2013) Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. PLoS ONE 8:e64526","journal-title":"PLoS ONE"},{"key":"2944_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2006.07.021","volume":"547","author":"M Bao","year":"2006","unstructured":"Bao M, Lou Y (2006) Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPK. Eur J Pharmacol 547:22\u201330","journal-title":"Eur J Pharmacol"},{"key":"2944_CR19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3892\/br.2016.636","volume":"4","author":"S Qiu","year":"2016","unstructured":"Qiu S, Sun G, Zhang Y, Li X, Wang R (2016) Involvement of the NF-kappaB signaling pathway in the renoprotective effects of isorhamnetin in a type 2 diabetic rat model. Biomed Rep 4:628\u2013634","journal-title":"Biomed Rep"},{"key":"2944_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/1940-6207.CAPR-11-0032","volume":"4","author":"JE Kim","year":"2011","unstructured":"Kim JE, Lee DE, Lee KW, Son JE, Seo SK, Li J et al (2011) Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer Prev Res 4:582\u2013591","journal-title":"Cancer Prev Res"},{"key":"2944_CR21","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.3892\/mmr.2015.4269","volume":"12","author":"S Hu","year":"2015","unstructured":"Hu S, Huang L, Meng L, Sun H, Zhang W, Xu Y (2015) Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogen-activated protein kinase kinase signaling pathways. Mol Med Rep 12:6745\u20136751","journal-title":"Mol Med Rep"},{"key":"2944_CR22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/mmr.2014.1886","volume":"9","author":"C Li","year":"2014","unstructured":"Li C, Yang X, Chen C, Cai S, Hu J (2014) Isorhamnetin suppresses colon cancer cell growth through the PI3KAktmTOR pathway. Mol Med Rep 9:935\u2013940","journal-title":"Mol Med Rep"},{"key":"2944_CR23","doi-asserted-by":"publisher","first-page":"e0120259&nbsp","DOI":"10.1371\/journal.pone.0120259","volume":"10","author":"Y Luo","year":"2015","unstructured":"Luo Y, Sun G, Dong X, Wang M, Qin M, Yu Y, et al (2015) Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via pi3k\/akt activation and HO-1 induction. PloS ONE 10: e0120259","journal-title":"PloS ONE"},{"key":"2944_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/HYPERTENSIONAHA.113.02083","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, Luo YX, Zhang R, Zhang XD, Chen HZ, Zhang Y et al (2014) Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension 63:119\u2013127","journal-title":"Hypertension"},{"key":"2944_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","volume":"61","author":"DS Jiang","year":"2013","unstructured":"Jiang DS, Bian ZY, Zhang Y, Zhang SM, Liu Y, Zhang R et al (2013) Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61:1193\u20131202","journal-title":"Hypertension"},{"key":"2944_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1536\/ihj.51.277","volume":"51","author":"JP Konhilas","year":"2010","unstructured":"Konhilas JP, Boucek DM, Horn TR, Johnson GL, Leinwand LA (2010) The role of MEKK1 in hypertrophic cardiomyopathy. Int Heart J 51:277\u2013284","journal-title":"Int Heart J"},{"key":"2944_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbadis.2013.11.018","volume":"1842","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zhang XF, Gao L, Liu Y, Jiang DS, Chen K et al (2014) Growth\/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction. Biochim Biophys Acta 1842:232\u2013244","journal-title":"Biochim Biophys Acta"},{"key":"2944_CR28","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2174\/138161211796390976","volume":"17","author":"T Aoyagi","year":"2011","unstructured":"Aoyagi T, Matsui T (2011) Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des 17:1818\u20131824","journal-title":"Curr Pharm Des"},{"key":"2944_CR29","doi-asserted-by":"publisher","first-page":"32841","DOI":"10.1074\/jbc.M513087200","volume":"281","author":"B DeBosch","year":"2006","unstructured":"DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ (2006) Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281:32841\u201332851","journal-title":"J Biol Chem"},{"key":"2944_CR30","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","volume":"153","author":"PH Sugden","year":"2008","unstructured":"Sugden PH, Fuller SJ, Weiss SC, Clerk A (2008) Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153:S137\u2013S153","journal-title":"Br J Pharmacol"},{"key":"2944_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.yjmcc.2011.10.015","volume":"52","author":"CF Clemente","year":"2012","unstructured":"Clemente CF, Xavier-Neto J, Dalla Costa AP, Consonni SR, Antunes JE, Rocco SA et al (2012) Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways. J Mol Cell Cardiol 52:493\u2013501","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl 2","key":"2944_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1467-789X.2012.01038.x","volume":"13","author":"Z Yang","year":"2012","unstructured":"Yang Z, Ming XF (2012) mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases. Obes Rev 13(Suppl 2):58\u201368","journal-title":"Obes Rev"},{"key":"2944_CR33","doi-asserted-by":"publisher","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey A, Ojamaa K (2006) Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281:20666\u201320672","journal-title":"J Biol Chem"},{"key":"2944_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95\u2013105","journal-title":"Biochem J"},{"key":"2944_CR35","doi-asserted-by":"publisher","first-page":"13728","DOI":"10.1074\/jbc.M413155200","volume":"280","author":"MD Jacobs","year":"2005","unstructured":"Jacobs MD, Black J, Futer O, Swenson L, Hare B, Fleming M et al (2005) Pim-1 ligand-bound structures reveal the mechanism of serine\/threonine kinase inhibition by LY294002. J Biol Chem 280:13728\u201313734","journal-title":"J Biol Chem"},{"key":"2944_CR36","first-page":"575","volume":"5","author":"L Chen","year":"2012","unstructured":"Chen L, Han L, Shi Z, Zhang K, Liu Y, Zheng Y, et al (2012) LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K\/Akt pathway. Mol Med Rep 5:575\u2013579","journal-title":"Mol Med Rep"},{"key":"2944_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2008.09.094","volume":"377","author":"P Liu","year":"2008","unstructured":"Liu P, Xu B, Li J, Lu H (2008) LY294002 inhibits leukemia cell invasion and migration through early growth response gene 1 induction independent of phosphatidylinositol 3-kinase-Akt pathway. Biochem Biophys Res Commun 377:187\u2013190","journal-title":"Biochem Biophys Res Commun"}],"updated-by":[{"DOI":"10.1007\/s11010-021-04288-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000}}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-2944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-017-2944-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-2944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T06:13:48Z","timestamp":1719036828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-017-2944-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1007\/s11010-017-2944-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]},"assertion":[{"value":"8 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11010-021-04288-x","URL":"https:\/\/doi.org\/10.1007\/s11010-021-04288-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}